Literature DB >> 22609057

Impact of diabetes on the presenting features of tuberculosis in hospitalized patients.

S Carreira1, J Costeira, C Gomes, J M André, N Diogo.   

Abstract

INTRODUCTION: Diabetes mellitus (DM) is a risk factor for tuberculosis (TB) and may modify its presenting features. The aim of this study was to find out the influence of DM on clinical, radiological and treatment features of TB in hospitalized patients.
MATERIAL AND METHODS: In a retrospective study we reviewed the records of 123 patients with TB and DM admitted from 2000 to 2008 and compared this group with another one of 123 patients with TB without DM.
RESULTS: Although in both groups multilobar lung lesions predominated, there were more cases of isolated lower lung field (LLF) involvement in diabetics than in nondiabetics (10.6% vs 3.3% p=0.03). Cavitary lesions were less frequent (63.4% vs 82.1% p=0.01) and extra-pulmonary TB manifestations were more frequent (28.5% vs 16.3% p=0.02) in diabetics than in nondiabetics. There were no significant differences between groups regarding multidrug resistant - TB (MDR-TB) and adverse effects of anti-tuberculosis drugs. The in-hospital mortality was higher in diabetics (8.1% vs 0.8% p=0.01), but using a binary logistic regression there was significant difference in mortality only in respect to the variable MDR-TB.
CONCLUSIONS: This study showed that DM affected some clinical and radiological presenting features in hospitalized TB patients. LLF involvement and extra-pulmonary TB manifestations were more frequent in diabetic patients than in nondiabetic ones.
Copyright © 2011 Sociedade Portuguesa de Pneumologia. Published by Elsevier España. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22609057     DOI: 10.1016/j.rppneu.2012.04.001

Source DB:  PubMed          Journal:  Rev Port Pneumol        ISSN: 0873-2159


  7 in total

1.  BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.

Authors:  Cristian Alfredo Segura-Cerda; Brenda Marquina-Castillo; Vasti Lozano-Ordaz; Dulce Mata-Espinosa; Jorge Alberto Barrios-Payán; Manuel O López-Torres; Michel de Jesús Aceves-Sánchez; Helle Bielefeldt-Ohmann; Rogelio Hernández-Pando; Mario Alberto Flores-Valdez
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

2.  Burden of diabetes among patients with tuberculosis: 10-year experience from a tertiary care referral teaching hospital in South India.

Authors:  Devasahayam Jesudas Christopher; Lakshmanan Jeyaseelan; Joy Sarojini Michael; Balaji Veeraraghavan; Marie Therese Manipadam; Thambu David; Mayank Gupta; Bijesh Yadav
Journal:  Lung India       Date:  2020 May-Jun

3.  Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis.

Authors:  Balewgizie Sileshi Tegegne; Melkamu Merid Mengesha; Andreas A Teferra; Mamaru Ayenew Awoke; Tesfa Dejenie Habtewold
Journal:  Syst Rev       Date:  2018-10-15

Review 4.  Changes in Host Response to Mycobacterium tuberculosis Infection Associated With Type 2 Diabetes: Beyond Hyperglycemia.

Authors:  Cristian Alfredo Segura-Cerda; Wendy López-Romero; Mario Alberto Flores-Valdez
Journal:  Front Cell Infect Microbiol       Date:  2019-10-04       Impact factor: 5.293

5.  BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.

Authors:  Cristian Alfredo Segura-Cerda; Brenda Marquina-Castillo; Vasti Lozano-Ordaz; Dulce Mata-Espinosa; Jorge Alberto Barrios-Payán; Manuel O López-Torres; Michel de Jesús Aceves-Sánchez; Helle Bielefeldt-Ohmann; Rogelio Hernández-Pando; Mario Alberto Flores-Valdez
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

6.  Diabetes mellitus is associated with increased mortality during tuberculosis treatment: a prospective cohort study among tuberculosis patients in South-Eastern Amahra Region, Ethiopia.

Authors:  Mahteme Haile Workneh; Gunnar Aksel Bjune; Solomon Abebe Yimer
Journal:  Infect Dis Poverty       Date:  2016-03-21       Impact factor: 4.520

Review 7.  Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains.

Authors:  H M Adnan Hameed; Md Mahmudul Islam; Chiranjibi Chhotaray; Changwei Wang; Yang Liu; Yaoju Tan; Xinjie Li; Shouyong Tan; Vincent Delorme; Wing W Yew; Jianxiong Liu; Tianyu Zhang
Journal:  Front Cell Infect Microbiol       Date:  2018-04-10       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.